AI-Powered Oral Board Training Is Available to CTSNet Users Now!

You are here:

Thoracic

Year in Review: Lung Cancer

November 7, 2019

Submitted by: Mark Ferguson

Source: MedPage Today

Source URL: https://www.medpagetoday.com/hematologyoncology/lungcancer/83163?xid=nl_mpt_DHE_…

Keywords:

Author(s): Charles Bankhead

This brief overview of recently presented improvements in lung cancer therapy highlights the substantial benefits of newer chemotherapy and immunotherapy regimens that are transforming the outlooks of many patients with advanced lung cancer.

Add Comments Cancel reply

You must be logged in to post a comment.

ADD TO PLAYLIST

REMOVE FROM PLAYLIST

Rate this

Click on a star to rate it.

Average rating / 5. Vote count:

No votes so far. Be the first to rate it.

Related Content

Podcast

The Beat With Joel Dunning Ep. 174: Surgical Treatment of Atrial Fibrillation

By: Joel Dunning

JANS Article

CT Findings Maintains the Predictive Performance of an Existing Radiograph-Based Donor Lung Acceptability Score

By: Akshay Patel

Video

VATS Resection of a 10-Centimeter Mediastinal Mass With Subxiphoid Removal

By: Joel Dunning

Podcast

The Beat With Joel Dunning Ep. 173: Uniportal Robotics in the UAE

By: Joel Dunning

Video

Phrenic Nerve Pacing Using a Subxiphoid Robotic Approach Without Lung Isolation

By: Joel Dunning

JANS Article

Clinical Responses to Tarlatamab Among Patients With Pulmonary Carcinoid

By: Akshay Patel

JANS Article

Effect of Surgical Exposure on Outcomes in BLTx: Insight From the International ECLS Registry

By: Shrikar Modukuri

Video

Robotic Radical Thymectomy for Myasthenia Gravis: Left-Sided Approach

By: Pramod Reddy Kandakure

Podcast

The Beat With Joel Dunning Ep. 172: Intraoperative AI Copilot in Robotic Cardiac Surgery

By: Joel Dunning

JANS Article

Tumor Mutational Burden as a Predictor of Immune-Related Adverse Events in Patients With Advanced Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: A Brief Report

By: Akshay Patel